Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
National Cancer Institute (NCI)
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of California, San Francisco
Case Comprehensive Cancer Center